Group
OpenWho we are
OpenGovernance
OpenWhat we do
OpenOur strategy
OpenInnovation
OpenResearch & Development
OpenGlobal markets & Technologies
OpenSustainable development
OpenGroup fundamentals
OpenExtra financial regulations
OpenIndustry
OpenMarkets
OpenProcesses
OpenDiseases
OpenPublic health challenges
OpenElectronics
OpenEngineering & Construction
OpenScience & New energies
OpenLarge projects
Open
of innovation expenses in 2020
partnerships with industrial partners, academics and start-ups
employees contributing to innovation
Innovation serving the energy transition
The wide range of innovative technologies and solutions in the field of energy transition and in the environment protection, reinforced by the strength of digital and strong integration within the ecosystems, allow the Innovation teams to contribute to the Group’s sustainable growth, which commits to reaching carbon neutrality by 2050.
In 2020, Air Liquide dedicated 100 million euros of its innovation expenses to the energy transition, particularly to the development of low carbon hydrogen and biomethane.
Approximately 8 billion euros will be invested in the low-carbon hydrogen supply chain by 2035.
Biomethane serving the circular economy: providing energy by recovering waste
Air Liquide purifies biogas from the fermentation of organic and agricultural wastes to obtain biomethane. It is then injected into the domestic grid or liquefied for transportation, storage and distribution as a clean alternative fuel or as industrial fuel.
- 20 biomethane production units around the world, including 2 inaugurated in 2020
- 250,000 tons of CO2 avoided over the last 3 years
Discover more on energy transition by Air Liquide on our On Air Magazine
Innovation in the Healthcare sector
Air Liquide is one of the world leaders in this constantly changing business sector. The Group is committed, alongside patients, healthcare professionals and hospitals, to contributing to making the healthcare system more efficient, in particular with digital.
The Air Liquide Healthcare offer in telemedicine: Chronic Care Connect
In 2020, Air Liquide continued to deploy its medical remote offer Chronic Care Connect Cardiac, for patients with heart failure. It brings together a medical decision support software platform which uses clinical remote medical data processed by predictive algorithms, with a monitoring center in which nurses check the relevance of the alerts generated. The aim of Chronic Care Connect is to improve the quality of patient care, to reduce unplanned hospital readmissions and the associated costs by optimizing care after hospitalization.
A reduction of 21% in the risk of first hospitalization (a)
Discover more on innovation in Healthcare in our On Air Magazine
Digital at the heart of innovation
Digital is now part of all new offers and is also at the heart of all efficiency initiatives, as it allows more efficient processes, a better Customer and User experience and a greater efficiency to enhance operational excellence.
Data for predictive maintenance
Air Liquide set up the international program Smart & Innovative Operations (SIO) which relies on on data analysis to improve the reliability of oxygen, nitrogen and hydrogen plants and optimize energy consumption.
- +200 sites with predictive maintenance
- +600 early detections of maintenance needs
Discover digitization at Air Liquide on our On Air Magazine
Air Liquide also brings innovative solutions thanks to the development of deep tech, whether in electronics, extreme cryogenics or space exploration.
Innovation with ecosystems
Air Liquide’s innovation strategy is part of an open ecosystem. It relies on our Innovation Campuses, in Europe, in America and in Asia, and on the Campus Technology Grenoble in France.
The Innovation and Development Division teams gather Research & Development, Digital & IT teams (including Alizent), Global Markets & Technologies, i-lab (our innovation lab focused on understanding the new trends) and ALIAD teams.
Our different ways of partnering with startups
Our teams dedicated to innovation
-
we are open & curious
Working with ecosystems - both internal and external, such as customers, academics, startups, suppliers - is part of our strategy. Developing an inclusive approach is a prerequisite to imagine new solutions meeting user’s needs and behaviors.
-
we challenge to develop disruptive solutions
Challenging our habits, our ways of working and doing business, and sharing our ideas are the cornerstone of our innovation approach. We develop an entrepreneurial mindset based on a try & learn approach, and are a source of inspiration for the Group.
Credit : Franck Dunouau
-
we deliver business solutions
We are result-oriented and contribute to the business with operation excellence and sustainable growth. We focus on impactful technologies, including data and AI, and measure the outcomes. With our business entities and Innovation Campuses, we are ultra connected with the business.
-
we always put customer adoption first
Thanks to our proximity with business teams, we start with customer pain points and in-depth understanding of the markets & new usages. We test & iterate with our customers and end-users. Developing a differentiated and unparalleled user experience is our priority.
Credit : Franck Dunouau
/
(a) OSICAT (Optimisation de la Surveillance ambulatoire des Insuffisants Cardiaques par Télécardiologie) Clinical Trial, issued in 2020, including 990 cardiac patients in France, on the risk of first hospitalization. Although the primary endpoint is not reached, the results show a 21% reduction in the risk of occurrence of the first hospitalization for heart failure.